Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05259696
Title Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) (GLIMMER-01)
Acronym GLIMMER-01
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Palleon Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
University of Southern California Los Angeles California 90033 United States Details
Stanford Health Care Stanford California 94305 United States Details
Yale University Cancer Center New Haven Connecticut 06520 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Columbia University New York New York 10032 United States Details
Providence Cancer Institute Portland Oregon 97213 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field